ABVX Live signals | Maximize Profits with Getagraph.com

BUY 127371 min ago

@ $12.38

Issued: 9 Feb 2024 @ 14:43

Return: 17.61%

Previous signal: Feb 7 - 15:52

Previous signal: Sell

Return: -1.59 %

Live Chart Being Loaded With Signals

Commentary (7 May 2024 @ 16:00):

Stats
Today's Volume	32 782.00
Average Volume	68 186.00
Market Cap	916.08M
Next earnings date	( $0 ) 2024-05-30
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.95
ATR14	$0.125 (0.86%)

Abivax SA American Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Abivax SA American Financials

Annual	2023
Revenue:	$4.62M
Gross Profit:	$3.91M (84.70 %)
EPS:	$-3.43

FY	2023
Revenue:	$4.62M
Gross Profit:	$3.91M (84.70 %)
EPS:	$-3.43

FY	2022
Revenue:	$0
Gross Profit:	$-110 000 (0.00 %)
EPS:	$-3.13

Financial Reports:

No articles found.

Abivax SA American

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.